Metabolic Impact of Intermittent Fasting in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies

Summary

This meta-analysis pooled 7 randomized diet-controlled interventional studies of intermittent fasting in adults with type-2 diabetes (338 total participants, mean BMI 35.7, baseline HbA1c 8.8 percent) to ask the headline question: does IF beat standard caloric-restriction diets for T2D? The answer was nuanced. Intermittent fasting produced significantly more weight loss — about 1.9 kg more than standard diet over comparable durations, with the effect strongest in heavier participants and shorter studies. But the HbA1c effect was a wash: IF was not associated with any further HbA1c reduction beyond what a standard diet achieved (point estimate −0.11 percent, confidence interval crossing zero). Other glycemic markers (fasting glucose, insulin) showed mixed results without clear superiority for either approach. The honest synthesis: at the IF protocols typically studied (mostly 16:8 time-restricted eating, some 5:2 alternate-day patterns), IF helps adherence to a calorie deficit and produces more weight loss, but the metabolic improvement is mediated through weight loss, not through any unique fasting-specific mechanism.